Harbour Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4K | Sell |
644
-6
| -0.9% | -$498 | ﹤0.01% | 1790 |
|
|
2025
Q1 | $52.7K | Sell |
650
-34
| -5% | -$2.76K | ﹤0.01% | 1731 |
|
|
2024
Q4 | $61.6K | Hold |
684
| – | – | ﹤0.01% | 1606 |
|
|
2024
Q3 | $67.6K | Sell |
684
-3,794
| -85% | -$375K | ﹤0.01% | 1514 |
|
|
2024
Q2 | $415K | Sell |
4,478
-291
| -6% | -$27K | 0.01% | 668 |
|
|
2024
Q1 | $453K | Sell |
4,769
-28
| -0.6% | -$2.66K | 0.02% | 630 |
|
|
2023
Q4 | $428K | Hold |
4,797
| – | – | 0.02% | 583 |
|
|
2023
Q3 | $350K | Sell |
4,797
-30
| -0.6% | -$2.19K | 0.02% | 599 |
|
|
2023
Q2 | $402K | Buy |
4,827
+3,402
| +239% | +$283K | 0.02% | 556 |
|
|
2023
Q1 | $109K | Sell |
1,425
-20
| -1% | -$1.52K | 0.01% | 1004 |
|
|
2022
Q4 | $120K | Sell |
1,445
-320
| -18% | -$26.6K | 0.01% | 937 |
|
|
2022
Q3 | $131K | Hold |
1,765
| – | – | 0.01% | 861 |
|
|
2022
Q2 | $131K | Buy |
+1,765
| New | +$131K | 0.01% | 861 |
|
|
2021
Q4 | $229K | Sell |
2,044
-7,645
| -79% | -$857K | 0.01% | 666 |
|
|
2021
Q3 | $1.22M | Buy |
9,689
+2,009
| +26% | +$253K | 0.04% | 397 |
|
|
2021
Q2 | $1.04M | Buy |
7,680
+445
| +6% | +$60.3K | 0.03% | 451 |
|
|
2021
Q1 | $981K | Buy |
+7,235
| New | +$981K | 0.04% | 420 |
|